Karolinska Universitetssjukhuset i Solna

Stockholm 17176

0 studies enrolling now · 4 studies all time

What they study most

Advanced Cancer, Biliary Tract Cancer, Blood Coagulation Disorders, Chronic Lymphocytic Leukemia, Hemophilia A, Metastatic Cancer, Small Lymphocytic Lymphoma, Solid Tumors Harboring NTRK Fusion

Studies at this site

• A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer — Running, not enrolling
• A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) — Running, not enrolling
• A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children — Running, not enrolling
• Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A — Completed